<DOC>
	<DOCNO>NCT00052325</DOCNO>
	<brief_summary>RATIONALE : Mistletoe may help body build immune response may improve quality life help patient live comfortably . PURPOSE : This phase II trial study mistletoe see well work treat patient receive palliative chemotherapy stage IIIB stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>Mistletoe Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether supplemental treatment mistletoe increase immune function ( determined total lymphocyte count , eosinophil count , lymphocyte subset analysis ) patient stage IIIB IV non-small cell lung cancer receive palliative chemotherapy . - Determine tolerability drug patient . - Correlate immune function quality life patient treated drug . OUTLINE : This open-label , non-randomized , multicenter study . Patients receive mistletoe subcutaneously three time week 15 week . Dose mistletoe increase week 2 3 every 3 week maximum response see , dose-limiting toxicity occur , study end . Quality life assess baseline week 3 , 6 , 9 , 12 , 15 . PROJECTED ACCRUAL : Not specify</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Stage IIIB IV nonsmall cell lung cancer Newly diagnose disease Planning receive standard chemotherapy either carboplatin plus paclitaxel cisplatin plus gemcitabine Refused ineligible participate experimental chemotherapy clinical trial PATIENT CHARACTERISTICS : Age 18 Performance status Karnofsky 60100 % Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Not pregnant No AIDS Able selfreport quality life No known allergy Viscum album Linnaeus PRIOR CONCURRENT THERAPY : Biologic therapy No concurrent mistletoe product Chemotherapy See Disease Characteristics Endocrine therapy No concurrent steroid adrenocorticotropic hormone therapy Radiotherapy Not specify Surgery Not specify Other No concurrent participation clinical trial No concurrent mushroom glucan proteoglycan extract No concurrent thymus extract No concurrent nononcologic immunosuppressive therapy ( e.g. , therapy rheumatoid arthritis organ transplantation )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
</DOC>